Anaptysbio (ANAB) Assets Average (2017 - 2026)

Anaptysbio's Assets Average history runs 10 years deep, the most recent figure standing at $347.0 million for Q1 2026.

• Quarterly Assets Average fell 23.38% year-over-year to $347.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $347.0 million (down 23.38% YoY) and the FY2025 annual result came in at $424.1 million, down 9.4% from the prior year.
• Assets Average was $347.0 million for Q1 2026 at Anaptysbio, down from $358.7 million in the prior quarter.
• Across five years, Assets Average topped out at $634.1 million in Q1 2022 and bottomed at $344.2 million in Q3 2025.
• A 5-year average of $484.6 million and a median of $469.9 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average jumped 56.0% — and 2025, when it decreased 26.58%.
• Anaptysbio's Assets Average stood at $614.4 million in 2022, then declined by 23.53% to $469.9 million in 2023, then increased by 3.99% to $488.6 million in 2024, then dropped by 26.58% to $358.7 million in 2025, then declined by 3.26% to $347.0 million in 2026.
• Business Quant data shows ANAB's Assets Average at $347.0 million in Q1 2026, $358.7 million in Q4 2025, and $344.2 million in Q3 2025.